Pricing

Praxis Precision Medicines, Inc (PRAX)

followers ยท
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Marcio Souza
Employees: 110
Web site: praxismedicines.com
99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
617-300-8460
Stock Split History
Date Ratio
2023-11-29 1:15
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available